Quantum Biopharma (QNTM) Change in Intangibles (2025 - 2026)
Quantum Biopharma (QNTM) reported Change in Intangibles of $68980.0 for Q1 2026, down 74.29% on a YoY basis from $268293.0 in Q1 2025, and down 82.45% sequentially from $393004.0 in Q4 2025.
Quantum Biopharma (QNTM) Change in Intangibles (2025 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 2 years of Change in Intangibles data on file, last reported at $68980.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Intangibles fell 74.29% year-over-year to $68980.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (up 757.69% YoY), and the FY2025 full-year result was $2.5 million, changed N/A from the prior year.
- Change in Intangibles eased to $68980.0 in Q1 2026, from $393004.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $1.8 million in Q3 2025 to a low of $68980.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | Quantum Biopharma | 12.84 Bn | 12.84 Bn | - | 68,980.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,980.00 |
| Mar 31, 2026 | 68,980.00 |
| Dec 31, 2025 | 393,004.00 |
| Dec 31, 2025 | 393,004.00 |
| Sep 30, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 85,720.00 |
| Jun 30, 2025 | 85,720.00 |
| Mar 31, 2025 | 268,293.00 |
| Mar 31, 2025 | 268,293.00 |